Articles

Results from the GENIUS Trial: Maintenance Therapy with Gefitinib/Pemetrexed vs Pemetrexed for Metastatic Lung Adenocarcinoma with No Sensitizing EGFR Mutation

ASCO 2015 – Lung Cancer

First-line Monotherapy with Nivolumab in Advanced NSCLC: Safety, Efficacy, and Correlation of Outcomes with PD-L1 Expression

ASCO 2015 – Lung Cancer

PD-L1, PD-1, and CTLA-4 as Prognostic Biomarkers in Resected NSCLC

ASCO 2015 – Lung Cancer

ASCEND-3: a Phase 2 Study of Ceritinib in ALK Inhibitor-Naïve Adult Patients with ALK+ NSCLC

ASCO 2015 – Lung Cancer

GASTO 1001: a Phase 2 Trial of Neoadjuvant Bevacizumab plus Pemetrexed and Carboplatin in Patients with Unresectable Stage III Lung Adenocarcinoma

ASCO 2015 – Lung Cancer

Final Follow-up Results from RADIANT: Adjuvant Erlotinib Vs Placebo Following Complete Tumor Resection in Patients with Stage IB–IIIA EGFR-positive NSCLC

ASCO 2015 – Lung Cancer

The ONS 40th Annual Congress

The 2015 Annual Congress of the Oncology Nursing Society (ONS) marks the 40th anniversary of the organization. Presentations and events included the tried and true and the new. Read More ›

Boosting Uptake of the HPV Vaccine

The United States lags behind other developed countries in uptake of the human papillomavirus (HPV) vaccine, and nurses and other healthcare providers can improve the situation. Read More ›

Palliative Care and the Role of Nurses

Adding Rituximab to CHOP Improves Clinical Outcomes in Mantle-Cell Lymphoma

ASH 2014 – Castleman's Disease

Page 130 of 143